News about Global Pharma

India's Rising Role in the Global Pharma Supply Chain

One of the key drivers behind India’s growing role is its expansive manufacturing infrastructure. The country is home to more than 3,000 pharmaceutical companies and over 10,500 manufacturing units.

Global Pharma | 19/07/2025 | By Darshana |  293

Pharma Leaders Back UK Life Sciences Strategy, But ABPI Warns of Medicines Investment Gap

Pharmaceutical and medical technology leaders, including GSK, Sandoz, Accord Healthcare, Becton Dickinson, and Celltrion have welcomed the UK government’s new Life Sciences Sector Plan, recently unveiled as part of its flagship Industrial Strategy.

Global Pharma | 19/07/2025 | By Dineshwori |  247

Mallinckrodt Secures Irish High Court Approval for Merger with Endo

Mallinckrodt plc has announced that it has received the final ruling from the Irish High Court, clearing the way for its merger with Endo, Inc. to form a global, diversified therapeutics company.

Global Pharma | 19/07/2025 | By Mrinmoy Dey |  241

Cipla Appoints BNP and Associates as Secretarial Auditors for Five-Year Term

Cipla Limited has appointed M/s BNP and Associates as its Secretarial Auditors for a five-year term, commencing from the conclusion of the company’s 89th Annual General Meeting (AGM) and continuing until the conclusion of the 94th AGM.

Global Pharma | 19/07/2025 | By Dineshwori |  244

Oragenics, Sterling Pharma Solutions Ink Manufacturing Deal for Concussion Drug

Oragenics has partnered with Sterling Pharma Solutions for the GMP production of its lead drug candidate, ONP-002, for the treatment of concussion.

Global Pharma | 18/07/2025 | By Dineshwori |  274

Samsung Bioepis Partners with Harrow for US Commercialisation of Ophthalmology Biosimilars

Following the transition of commercial rights from Biogen back to Samsung Bioepis, Harrow will assume full responsibility for the commercialisation of both BYOOVIZ and OPUVIZ biosimilars in the US.

Global Pharma | 18/07/2025 | By Dineshwori |  346

BD Spins Off Biosciences and Diagnostics Business in USD 17.5B Merger with Waters

Becton, Dickinson and Company (BD) and Waters Corporation have entered into a definitive agreement to merge BD’s Biosciences and Diagnostic Solutions business with Waters in a deal valued at approximately USD 17.5 billion.

Global Pharma | 18/07/2025 | By Dineshwori |  1029

Lupin Receives GMP Certification from TGA Australia for Dabhasa API Facility in Gujarat

Lupin’s wholly-owned subsidiary, Lupin Manufacturing Solutions, has received GMP certification from Australia’s Therapeutic Goods Administration (TGA) for its API facility in Dabhasa, Gujarat.

Global Pharma | 18/07/2025 | By Mrinmoy Dey |  406

Novartis Names Mukul Mehta as Chief Financial Officer as Harry Kirsch Retires After 22 Years

Novartis has announced the appointment of Mukul Mehta as Chief Financial Officer (CFO) and member of the Executive Committee of Novartis (ECN), effective March 16, 2026.

Global Pharma | 17/07/2025 | By Dineshwori |  518

Sanofi India, Emcure Sign Exclusive Distribution Partnership for Anti-Diabetic Drugs

Sanofi India Ltd. has entered into an exclusive distribution and promotion agreement with Emcure Pharmaceuticals for its oral anti-diabetic brands, including Amaryl and Cetapin, aiming to expand patient access and strengthen diabetes care across India.

Global Pharma | 17/07/2025 | By Mrinmoy Dey |  389